Targeted review of maximum residue levels (MRLs) for azocyclotin and cyhexatin

In accordance with Article 43 of Regulation (EC) 396/2005, EFSA received a request from the European Commission to review the existing maximum residue levels (MRLs) for the non‐approved active substances azocyclotin and cyhexatin in view of the possible lowering of these MRLs. EFSA investigated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Bellisai, Giulia, Bernasconi, Giovanni, Binaglia, Marco, Brancato, Alba, Carrasco Cabrera, Luis, Castellan, Irene, Castoldi, Anna Federica, Chiusolo, Arianna, Crivellente, Federica, Del Aguila, Monica, Ferreira, Lucien, Santonja, German Giner, Greco, Luna, Istace, Frederique, Jarrah, Samira, Lanzoni, Anna, Leuschner, Renata, Mangas, Iris, Miron, Ileana, Nave, Stefanie, Panzarea, Martina, Parra Morte, Juan Manuel, Pedersen, Ragnor, Reich, Hermine, Ruocco, Silvia, Santos, Miguel, Scarlato, Alessia Pia, Terron, Andrea, Theobald, Anne, Tiramani, Manuela, Verani, Alessia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Reasoned Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251540/
https://www.ncbi.nlm.nih.gov/pubmed/37304356
http://dx.doi.org/10.2903/j.efsa.2023.8038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251540/
https://www.ncbi.nlm.nih.gov/pubmed/37304356
http://dx.doi.org/10.2903/j.efsa.2023.8038

Ejemplares similares